Clinical Trials Directory

Trials / Completed

CompletedNCT01366313

The Median Effective Dose (ED50) of Paracetamol and Morphine : A Study of Interaction Study

The Median Effective Dose (ED50) of Paracetamol and Morphine for Postoperative Patients: A Study of Interaction.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Procare Riaya Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of our study is to define the median effective analgesic doses (ED50) of paracetamol, morphine, and their combination and determination the nature of their interaction administered IV for postoperative pain after moderate painful surgery using up-and-down and isobolographic methods.

Detailed description

Ninety patients scheduled to undergo moderately painful surgery were included in one of three groups. Determination of median effective (ED50) doses was performed by the Dixon and Mood up-and-down method. Initial doses were 1.5g and 5mg, with dose adjustment intervals of 0.5g and 1 mg, in the paracetamol and morphine groups, respectively. The initial doses of paracetamol and morphine were 1.5g and 3mg, respectively in the paracetamol-morphine combination group with dose adjustment intervals of 0.25g for paracetamol and 0.5mg for morphine. Analgesic efficacy was defined as a decrease to less than 3 on a 0-10 numeric pain scale, 45 min after the beginning of drug administration. Isobolographic analysis was used to define the nature of their interaction.

Conditions

Interventions

TypeNameDescription
DRUGParacetamolinitial doses was 1.5g, with dose adjustment intervals of 0.5g . with maximum dose 2.5 g as an only starting dose / 24 h
DRUGMorphineInitial of morphine was 5mg, with dose adjustment intervals 1 mg .
DRUGParacetamol- MorphineThe initial doses of paracetamol and morphine were 1.5g and 3mg, respectively in the paracetamol-morphine combination group with dose adjustment intervals of 0.25g for paracetamol and 0.5mg for morphine.

Timeline

Start date
2007-09-01
Primary completion
2011-03-01
Completion
2011-03-01
First posted
2011-06-06
Last updated
2012-12-10

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT01366313. Inclusion in this directory is not an endorsement.